Latest Proof Snapshot
The March 2026 quarter showed the recovery taking hold, but it should not be annualized mechanically because part of the 35.1% year-over-year revenue increase came against an unusually depressed prior-year comparison. Net sales reached $1.311 bn, up 10.6% sequentially; reported diluted EPS was $0.21 versus a prior-year reported loss of $0.29, and adjusted diluted EPS was $0.57 versus $0.11. The cash signal improved but remained a single-quarter proof point: Q4 reported operating cash flow was $257.0 m, capex was $14.2 m, and company-reported free cash flow was $242.8 m. Management also guided the June 2026 quarter to $1.442-1.469 bn of revenue and $0.67-$0.71 of adjusted EPS, while inventory days fell from 201 in December to 185 in March and distributor inventory reached 26 days. The valuation test is whether that rebound produces durable post-capex cash after the channel restock phase, not just a strong snapback quarter.